top of page

Search Results

Results found for "Design Pharmaceuticals"

  • Dr. Evi Kostenis | Dr. GPCR Ecosystem

    Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical

  • Structure Based Design of Modulators of Purinergic GPCRs | Dr. GPCR Ecosystem

    Explore structure-based design of purinergic GPCR modulators with NIH scientist Kenneth A. . < Back Structure-Based Design of Modulators of Purinergic GPCRs March 12, 2026 at 2:00:00 PM 🔒 Watch The session is designed for PhD scientists, postdoctoral researchers, and industry professionals interested His research focuses on developing computational pipelines for rational ligand design targeting therapeutically

  • FAQ | Dr. GPCR Ecosystem

    These webinars are designed for scientists who want deep, data-driven discussion rather than surface-level chemists working on receptor targets • Structural biologists • Translational scientists • Biotech and pharmaceutical and graduate researchers entering drug discovery If you work directly with receptor systems, ligand design The content is highly relevant for biotech and pharmaceutical scientists. These programs are designed for scientists seeking advanced, mechanism-focused training in GPCR biology

  • A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • Dr. GPCR Team | Dr. GPCR Ecosystem

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery committed to leveraging his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

  • Structure-based discovery of functionally selective 5-HT1A receptor agonists

    He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the

  • Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • GPCR Webinars | Dr. GPCR Ecosystem

    These webinars are designed for scientists who want deep, data-driven discussion rather than surface-level chemists working on receptor targets • Structural biologists • Translational scientists • Biotech and pharmaceutical and graduate researchers entering drug discovery If you work directly with receptor systems, ligand design The content is highly relevant for biotech and pharmaceutical scientists. These programs are designed for scientists seeking advanced, mechanism-focused training in GPCR biology

  • A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. companies to advance the understanding and application of allosteric modulation. - Arthur will work on designing Pharmaceutical Industry Experiences and GPCR History Arthur shared his experiences in the pharmaceutical the clinical context and dialing in the desired effect, as well as the significance of rational drug design

  • Dr. Alexander S. Hauser | Dr. GPCR Ecosystem

    During his Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen, He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

  • Dr. David E. Gloriam | Dr. GPCR Ecosystem

    University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical each month retrieve reference data and access online tools for analysis, visualization, and experiment design

  • GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR

    Forefront of GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling, assay design Pharmechanics GPCR signaling & biased agonism expert regularly consulted by top pharma companies for assay design Members-only networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed The Masterclass is designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech, and pharmaceutical research.

  • Celtarys Research | Dr. GPCR Ecosystem

    Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari Ligands in GPCR Research GPCRs are one of the most important families of therapeutic targets in the pharmaceutical dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design Custom Development Tailored fluorescent probes designed for unique research requirements.

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral

  • Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem

    How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about

  • Dr. Samuel Hoare | Dr. GPCR Ecosystem

    data analyst and the founder of Pharmechanics LLC , a consultancy and data analysis company supporting pharmaceutical Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences

  • Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem

    “I think I don’t have a linear trajectory… the beauty of seeing molecule design and reactions—thinking you can create molecules—was really exciting.” – Alessandro Nicoli He studied pharmaceutical chemistry in Padua, where his fascination with molecular design first took shape. close to experimental structures, provided a powerful starting point for docking, dynamics, and ligand design—especially He obtained an MSc degree in Chemistry and Pharmaceutical Technology from the University of Padua (Italy

  • GPCR Masterclass Live Sessions | Dr. GPCR Ecosystem

    Structure-Based Design of Modulators of Purinergic GPCRs Dr. Ken Jacobson & Dr. Matteo Pavan | NIH Structure-Based Drug Design Details Using iPSC-derived models to study GPCR function The Masterclass is designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech, and pharmaceutical research. Experts explain how they think about pharmacological data, experimental design, and discovery challenges—insight

  • GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem

    Sokhom Pin shares how he built a biotech career around GPCRs, designed a custom PhD path, and led teams Designing a Non-Traditional PhD While working full-time, Sokhom architected a one-of-a-kind PhD program Sokhom Pin Sokhom Pin is a receptor pharmacologist with over 20 years of drug discovery research in the pharmaceutical

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development

  • Revvity | Dr. GPCR Ecosystem

    internalization with pHSense pHSense™ probes are optimized reagents for plate readers, specifically designed Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity View Reagents Explore Revvity’s GPCR Assay Technologies Tools designed to illuminate every step of GPCR She has been leading collaborative projects with public research institutes and pharmaceutical companies A Tool Designed for Real Research Needs Built on more than two decades of GPCR assay innovation, pHSense

  • Dr. Christel Menet | Dr. GPCR Ecosystem

    I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical

  • Dr. Elva Zhao | Dr. GPCR Ecosystem

    Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical

  • Dr. Annette Gilchrist | Dr. GPCR Ecosystem

    Gilchrist is also an associate professor at the Department of Pharmaceutical Sciences.

  • Scott Struthers | Dr. GPCR Ecosystem

    Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused

  • Dr. Hannes Schihada | Dr. GPCR Ecosystem

    By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb

  • Dr. Graham Ladds | Dr. GPCR Ecosystem

    These investigations have enabled him to foster strong collaborations with the pharmaceutical industry

  • Dr. Brian Arey | Dr. GPCR Ecosystem

    He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

  • Dr. Brian Arey | Dr. GPCR Ecosystem

    He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility

bottom of page